Examkin

Soru

Zorluk: KolayClinical Preventive Services and Screening

An infant, aged 12 months, is brought to the pediatric clinic by his parents for a routine health maintenance visit. The child has been receiving high-dose systemic corticosteroids (2 mg/kg/day of prednisone) for the past month to treat severe immune thrombocytopenia. The parents note that he has had a mild runny nose and an occasional cough for the last two days. Developmentally, he can pull to stand and cruise along furniture but does not walk independently, and he specifically says "mama" and "dada". Vital signs are within normal limits for his age. Physical examination reveals clear rhinorrhea and mild, bilateral expiratory wheezing, with no increased work of breathing. Which of the following is the most appropriate action regarding this patient's care today?

  1. Administer the scheduled inactivated vaccines but defer the live-attenuated vaccines.Cevap
  2. B
    Administer all routine age-appropriate immunizations including the measles-mumps-rubella (MMR) vaccine.
  3. C
    Refer the patient for a formal developmental evaluation due to delayed motor and language milestones.
  4. D
    Prescribe an inhaled corticosteroid and beta-agonist therapy for new-onset pediatric asthma.
  5. E
    Prescribe a course of oral amoxicillin-clavulanate to treat the current respiratory infection.

Cevap

Administer the scheduled inactivated vaccines but defer the live-attenuated vaccines.
The most appropriate action is to provide the safe, inactivated vaccines while deferring the live-attenuated vaccines. A 12-month well-child visit typically includes the administration of the first doses of the MMR and varicella vaccines, which are live-attenuated. However, this patient is receiving high-dose systemic corticosteroids (defined as 2 mg/kg/day or greater, or 20 mg/day or greater of prednisone for more than 14 days). This treatment causes profound immunosuppression. In such states, live-attenuated vaccines are strictly contraindicated because the patient's immune system cannot clear the attenuated virus, risking severe, disseminated infection. The patient should receive appropriate inactivated vaccines, as they do not carry a risk of vaccine-strain infection, though the overall immune response may be blunted.

Adım Adım Çözüm

1
Evaluate the patient's current medication list and immune status.
The patient is on high-dose systemic corticosteroids (2 mg/kg/day for 1 month), which induces a state of severe immunosuppression.
Immunosuppression status directly dictates the safety of clinical preventive services, specifically vaccinations.
2
Identify the vaccines typically indicated at the 12-month well-child visit.
Routine 12-month vaccines include both inactivated vaccines and live-attenuated vaccines, such as MMR and Varicella.
Determining the schedule is necessary to know which specific interventions are planned for today.
3
Apply contraindication guidelines for the indicated vaccines.
Live-attenuated vaccines must be withheld in severely immunocompromised patients due to the risk of uncontrolled vaccine-strain infection. Inactivated vaccines can safely be administered.
This ensures the safe delivery of preventive care while avoiding iatrogenic harm.

Anahtar Kavram

Live-attenuated vaccines (such as MMR and Varicella) are contraindicated in patients receiving immunosuppressive therapy, including high-dose systemic corticosteroids.
Bu soruyu puanla

Konular

Clinical Preventive Services and Screening

Bu konudan daha fazla soru